BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ortiz M, Jacas C, Córdoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. Journal of Hepatology 2005;42:S45-53. [DOI: 10.1016/j.jhep.2004.11.028] [Cited by in Crossref: 178] [Cited by in F6Publishing: 166] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Tarnacka B, Szeszkowski W, Gołębiowski M, Członkowska A. Metabolic changes in 37 newly diagnosed Wilson's disease patients assessed by magnetic resonance spectroscopy. Parkinsonism & Related Disorders 2009;15:582-6. [DOI: 10.1016/j.parkreldis.2009.02.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen H, Zhu X, Yang M, Liu B, Zhang Y, Wang Y, Teng G. Changes in the regional homogeneity of resting-state brain activity in minimal hepatic encephalopathy. Neuroscience Letters 2012;507:5-9. [DOI: 10.1016/j.neulet.2011.11.033] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
3 Spahr L, Coeytaux A, Giostra E, Hadengue A, Annoni JM. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial. Am J Gastroenterol. 2007;102:744-753. [PMID: 17222324 DOI: 10.1111/j.1572-0241.2006.01028.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
4 Zhang Z, Zhao YC, Cheng Y, Jian GD, Pan MX, Gao Y. Hybrid bioartificial liver support in cynomolgus monkeys with D-galactosamine-induced acute liver failure. World J Gastroenterol 2014; 20(46): 17399-17406 [PMID: 25516651 DOI: 10.3748/wjg.v20.i46.17399] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
5 Lauridsen MM, Schaffalitzky de Muckadell OB, Vilstrup H. Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests. Metab Brain Dis. 2015;30:1187-1192. [PMID: 26016624 DOI: 10.1007/s11011-015-9688-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
6 Prakash RK, Kanna S, Mullen KD. Evolving Concepts: The Negative Effect of Minimal Hepatic Encephalopathy and Role for Prophylaxis in Patients With Cirrhosis. Clinical Therapeutics 2013;35:1458-73. [DOI: 10.1016/j.clinthera.2013.07.421] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
7 Bajaj JS. Introduction and setting the scene: New nomenclature of hepatic encephalopathy and American Association for the Study of Liver Diseases/European Association for the Study of the Liver guidelines. Clin Liver Dis (Hoboken) 2017;9:48-51. [PMID: 30992956 DOI: 10.1002/cld.610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Nardelli S, Gioia S, Ridola L, Carlin M, Cioffi AD, Merli M, Riggio O, Spagnoli A. Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more? Dig Liver Dis 2021:S1590-8658(21)00333-9. [PMID: 34233863 DOI: 10.1016/j.dld.2021.06.019] [Reference Citation Analysis]
9 Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci. 2010;55:2381-2390. [PMID: 20508990 DOI: 10.1007/s10620-010-1249-7] [Cited by in Crossref: 128] [Cited by in F6Publishing: 119] [Article Influence: 10.7] [Reference Citation Analysis]
10 Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, Saeian K, Hafeezullah M, Bell DE, Sterling RK, Stravitz RT, Luketic V, White MB, Sanyal AJ. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138:2332-2340. [PMID: 20178797 DOI: 10.1053/j.gastro.2010.02.015] [Cited by in Crossref: 197] [Cited by in F6Publishing: 161] [Article Influence: 16.4] [Reference Citation Analysis]
11 Razek AA, Abdalla A, Ezzat A, Megahed A, Barakat T. Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted MR imaging and proton MR spectroscopy of the brain. Neuroradiology. 2014;56:885-891. [PMID: 25060166 DOI: 10.1007/s00234-014-1409-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
12 Bajaj JS, Heuman DM, Sanyal AJ, Hylemon PB, Sterling RK, Stravitz RT, Fuchs M, Ridlon JM, Daita K, Monteith P, Noble NA, White MB, Fisher A, Sikaroodi M, Rangwala H, Gillevet PM. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One. 2013;8:e60042. [PMID: 23565181 DOI: 10.1371/journal.pone.0060042] [Cited by in Crossref: 227] [Cited by in F6Publishing: 220] [Article Influence: 25.2] [Reference Citation Analysis]
13 Liu JY, Ding J, Lin D, He YF, Dai Z, Chen CZ, Cheng WZ, Wang H, Zhou J, Wang X. T2* MRI of minimal hepatic encephalopathy and cognitive correlates in vivo. J Magn Reson Imaging. 2013;37:179-186. [PMID: 23011760 DOI: 10.1002/jmri.23811] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sharma P, Kumar A, Singh S, Tyagi P, Kumar A. Inhibitory control test, critical flicker frequency, and psychometric tests in the diagnosis of minimal hepatic encephalopathy in cirrhosis. Saudi J Gastroenterol. 2013;19:40-44. [PMID: 23319037 DOI: 10.4103/1319-3767.105924] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
15 Gad YZ, Zaher AA, Moussa NH, El-desoky AE, Al-Adarosy HA. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis. Arab J Gastroenterol. 2011;12:58-61. [PMID: 21684474 DOI: 10.1016/j.ajg.2011.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
16 Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715-735. [PMID: 25042402 DOI: 10.1002/hep.27210] [Cited by in Crossref: 879] [Cited by in F6Publishing: 680] [Article Influence: 109.9] [Reference Citation Analysis]
17 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020;26:83-127. [PMID: 31918536 DOI: 10.3350/cmh.2019.0010n] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
18 Gómez-Ansón B, Román E, Fernández de Bobadilla R, Pires-Encuentra P, Díaz-Manera J, Núñez F, Martinez-Horta S, Vives-Gilabert Y, Pagonabarraga J, Kulisevsky J, Cordoba J, Guarner C, Soriano G. Alterations in cerebral white matter and neuropsychology in patients with cirrhosis and falls. PLoS One 2015;10:e0118930. [PMID: 25793766 DOI: 10.1371/journal.pone.0118930] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
19 Sharma P, Sharma BC. Predictors of minimal hepatic encephalopathy in patients with cirrhosis. Saudi J Gastroenterol. 2010;16:181-187. [PMID: 20616413 DOI: 10.4103/1319-3767.65189] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
20 Bragagnolo Jr. MA, Teodoro V, Lucchesi LM, Ribeiro TCDR, Tufik S, Kondo M. Detecção de encefalopatia hepática mínima através de testes neuropsicológicos e neurofisiológicos e o papel da amônia no seu diagnóstico. Arq Gastroenterol 2009;46:43-9. [DOI: 10.1590/s0004-28032009000100013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Viramontes Hörner D, Avery A, Stow R. The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review. J Clin Gastroenterol 2017;51:312-23. [PMID: 28059938 DOI: 10.1097/MCG.0000000000000789] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 4.4] [Reference Citation Analysis]
22 Albhaisi SAM, Bajaj JS. Cognitive Function in Liver Transplantation. Curr Transplant Rep 2020;7:31-7. [PMID: 32435574 DOI: 10.1007/s40472-020-00274-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Patel AV, Wade JB, Thacker LR, Sterling RK, Siddiqui MS, Stravitz RT, Sanyal AJ, Luketic V, Puri P, Fuchs M, Matherly S, White MB, Unser A, Heuman DM, Bajaj JS. Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score. Clin Gastroenterol Hepatol 2015;13:987-91. [PMID: 25445772 DOI: 10.1016/j.cgh.2014.09.049] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
24 Qi R, Zhang L, Wu S, Zhong J, Zhang Z, Zhong Y, Ni L, Zhang Z, Li K, Jiao Q. Altered resting-state brain activity at functional MR imaging during the progression of hepatic encephalopathy. Radiology. 2012;264:187-195. [PMID: 22509052 DOI: 10.1148/radiol.12111429] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 6.8] [Reference Citation Analysis]
25 Butz M, Timmermann L, Braun M, Groiss SJ, Wojtecki L, Ostrowski S, Krause H, Pollok B, Gross J, Südmeyer M. Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy. Acta Neurol Scand. 2010;122:27-35. [PMID: 20003084 DOI: 10.1111/j.1600-0404.2009.01246.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
26 Zhan C, Chen HJ, Gao YQ, Zou TX. Functional Network-Based Statistics Reveal Abnormal Resting-State Functional Connectivity in Minimal Hepatic Encephalopathy.Front Neurol. 2019;10:33. [PMID: 30761070 DOI: 10.3389/fneur.2019.00033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
27 Pantham G, Post A, Venkat D, Einstadter D, Mullen KD. A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis. Dig Dis Sci 2017;62:2166-73. [DOI: 10.1007/s10620-017-4630-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
28 Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, Puri P, Sterling RK, Luketic V, Stravitz RT, Siddiqui MS, Fuchs M, Thacker LR, Wade JB, Daita K, Sistrun S, White MB, Noble NA, Thorpe C, Kakiyama G, Pandak WM, Sikaroodi M, Gillevet PM. Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther 2014;39:1113-25. [PMID: 24628464 DOI: 10.1111/apt.12695] [Cited by in Crossref: 152] [Cited by in F6Publishing: 146] [Article Influence: 19.0] [Reference Citation Analysis]
29 Naderian M, Akbari H, Saeedi M, Sohrabpour AA. Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial. Middle East J Dig Dis 2017;9:12-9. [PMID: 28316761 DOI: 10.15171/mejdd.2016.46] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
30 Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol. 2009;28:5-16. [PMID: 19529896 DOI: 10.1007/s12664-009-0003-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
31 Qi R, Zhang LJ, Zhong J, Zhang Z, Ni L, Zheng G, Lu GM. Disrupted thalamic resting-state functional connectivity in patients with minimal hepatic encephalopathy. Eur J Radiol. 2013;82:850-856. [PMID: 23332976 DOI: 10.1016/j.ejrad.2012.12.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
32 Qi R, Zhang LJ, Luo S, Ke J, Kong X, Xu Q, Liu C, Lu H, Lu GM. Default mode network functional connectivity: a promising biomarker for diagnosing minimal hepatic encephalopathy: CONSORT-compliant article. Medicine (Baltimore) 2014;93:e227. [PMID: 25501083 DOI: 10.1097/MD.0000000000000227] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
33 Montgomery JY, Bajaj JS. Advances in the evaluation and management of minimal hepatic encephalopathy. Curr Gastroenterol Rep. 2011;13:26-33. [PMID: 20924726 DOI: 10.1007/s11894-010-0150-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
34 Stinton LM, Jayakumar S. Minimal hepatic encephalopathy. Can J Gastroenterol 2013;27:572-4. [PMID: 24106728 DOI: 10.1155/2013/547670] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
35 Bajaj JS, Saeian K, Christensen KM, Hafeezullah M, Varma RR, Franco J, Pleuss JA, Krakower G, Hoffmann RG, Binion DG. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol. 2008;103:1707-1715. [PMID: 18691193 DOI: 10.1111/j.1572-0241.2008.01861.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 162] [Article Influence: 13.0] [Reference Citation Analysis]
36 Kappus MR, Bajaj JS. Covert hepatic encephalopathy: Not as minimal as you might think. Clin Gastroenterol Hepatol. 2012;10:1208-1219. [PMID: 22728384 DOI: 10.1016/j.cgh.2012.05.026] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
37 Rabiee A, Ximenes RO, Nikayin S, Hickner A, Juthani P, Rosen RH, Garcia-Tsao G. Factors associated with health-related quality of life in patients with cirrhosis: a systematic review. Liver Int 2021;41:6-15. [PMID: 32998172 DOI: 10.1111/liv.14680] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
38 Shaw J, Bajaj JS. Covert Hepatic Encephalopathy: Can My Patient Drive? J Clin Gastroenterol 2017;51:118-26. [PMID: 28027071 DOI: 10.1097/MCG.0000000000000764] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
39 Bajaj JS, Ananthakrishnan AN, McGinley EL, Hoffmann RG, Brasel KJ. Deleterious effect of cirrhosis on outcomes after motor vehicle crashes using the nationwide inpatient sample. Am J Gastroenterol 2008;103:1674-81. [PMID: 18616657 DOI: 10.1111/j.1572-0241.2008.01814.x] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
40 Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol. 2007;47:67-73. [PMID: 17459511 DOI: 10.1016/j.jhep.2007.02.022] [Cited by in Crossref: 123] [Cited by in F6Publishing: 106] [Article Influence: 8.2] [Reference Citation Analysis]
41 Berenji Ardestani S, Balestra C, Bouzinova EV, Loennechen Ø, Pedersen M. Evaluation of Divers' Neuropsychometric Effectiveness and High-Pressure Neurological Syndrome via Computerized Test Battery Package and Questionnaires in Operational Setting. Front Physiol 2019;10:1386. [PMID: 31787904 DOI: 10.3389/fphys.2019.01386] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology. 2009;50:2014-2021. [PMID: 19787808 DOI: 10.1002/hep.23216] [Cited by in Crossref: 223] [Cited by in F6Publishing: 198] [Article Influence: 17.2] [Reference Citation Analysis]
43 Poh Z, Chang PE. A current review of the diagnostic and treatment strategies of hepatic encephalopathy. Int J Hepatol. 2012;2012:480309. [PMID: 23133760 DOI: 10.1155/2012/480309] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
44 Aghaei I, Saeedi Saravi SS, Ghotbi Ravandi S, Nozari M, Roudbari A, Dalili A, Shabani M, Dehpour AR. Evaluation of prepulse inhibition and memory impairments at early stage of cirrhosis may be considered as a diagnostic index for minimal hepatic encephalopathy. Physiol Behav 2017;173:87-94. [PMID: 28119160 DOI: 10.1016/j.physbeh.2017.01.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
45 Nabi E, Bajaj JS. Useful tests for hepatic encephalopathy in clinical practice. Curr Gastroenterol Rep. 2014;16:362. [PMID: 24357348 DOI: 10.1007/s11894-013-0362-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
46 Romero-Gómez M. Critical flicker frequency: it is time to break down barriers surrounding minimal hepatic encephalopathy. J Hepatol. 2007;47:10-11. [PMID: 17507110 DOI: 10.1016/j.jhep.2007.04.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
47 Wang JY, Zhang NP, Chi BR, Mi YQ, Meng LN, Liu YD, Wang JB, Jiang HX, Yang JH, Xu Y, Li X, Xu JM, Zhang G, Zhou XM, Zhuge YZ, Tian DA, Ye J, Liu YL. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China. World J Gastroenterol 2013; 19(30): 4984-4991 [PMID: 23946605 DOI: 10.3748/wjg.v19.i30.4984] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
48 Qi R, Zhang LJ, Zhong J, Zhu T, Zhang Z, Xu C, Zheng G, Lu GM. Grey and white matter abnormalities in minimal hepatic encephalopathy: a study combining voxel-based morphometry and tract-based spatial statistics. Eur Radiol. 2013;23:3370-3378. [PMID: 23839169 DOI: 10.1007/s00330-013-2963-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
49 Jacques J, Carrier P, Debette-gratien M, Sobesky R, Loustaud-ratti V. Encéphalopathie hépatique. La Presse Médicale 2016;45:46-59. [DOI: 10.1016/j.lpm.2015.02.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
50 Victor DW 3rd, Quigley EM. Hepatic encephalopathy involves interactions among the microbiota, gut, brain. Clin Gastroenterol Hepatol. 2014;12:1009-1011. [PMID: 24462627 DOI: 10.1016/j.cgh.2014.01.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
51 Luo S, Zhou ZM, Guo DJ, Li CM, Liu H, Wu XJ, Liang S, Zhao XY, Chen T, Sun D, Shi XL, Zhong WJ, Zhang W. Radiomics-based classification models for HBV-related cirrhotic patients with covert hepatic encephalopathy. Brain Behav 2021;11:e01970. [PMID: 33236529 DOI: 10.1002/brb3.1970] [Reference Citation Analysis]
52 Burroughs TK, Wade JB, Ellwood MS, Fagan A, Heuman DM, Fuchs M, Bajaj JS. Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans. Dig Dis Sci 2018;63:481-5. [PMID: 29313245 DOI: 10.1007/s10620-017-4894-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Bajaj JS, Heuman DM, Sterling RK, Sanyal AJ, Siddiqui M, Matherly S, Luketic V, Stravitz RT, Fuchs M, Thacker LR, Gilles H, White MB, Unser A, Hovermale J, Gavis E, Noble NA, Wade JB. Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy. Clin Gastroenterol Hepatol. 2015;13:1828-1835.e1. [PMID: 24846278 DOI: 10.1016/j.cgh.2014.05.011] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 8.8] [Reference Citation Analysis]
54 Mousa N, Abdel-Razik A, Zaher A, Hamed M, Shiha G, Effat N, Elbaz S, Elhelaly R, Hafez M, El-Wakeel N, Eldars W. The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial. Therap Adv Gastroenterol. 2016;9:684-691. [PMID: 27582881 DOI: 10.1177/1756283x16645049] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
55 Xu J, Ma R, Chen LF, Zhao LJ, Chen K, Zhang RB. Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials. Hepatobiliary Pancreat Dis Int 2014;13:354-60. [PMID: 25100119 DOI: 10.1016/s1499-3872(14)60280-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
56 Tsai CF, Liu CJ, Chen TJ, Chu CJ, Lin HC, Lee FY, Su TP, Lu CL. Increased incidence of orthopedic fractures in cirrhotic patients: a nationwide population-based study. J Hepatol 2013;58:706-14. [PMID: 23238105 DOI: 10.1016/j.jhep.2012.12.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
57 Soárez PCD, Oliveira AC, Padovan J, Parise ER, Ferraz MB. A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment. Arq Gastroenterol 2009;46:241-7. [DOI: 10.1590/s0004-28032009000300019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
58 Nakanishi H, Kurosaki M, Nakanishi K, Tsuchiya K, Noda T, Tamaki N, Yasui Y, Hosokawa T, Ueda K, Itakura J, Anami K, Asahina Y, Enomoto N, Higuchi T, Izumi N. Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopy. Hepatol Res 2014;44:319-26. [PMID: 23607661 DOI: 10.1111/hepr.12127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
59 Mostacci B, Ferlisi M, Baldi Antognini A, Sama C, Morelli C, Mondini S, Cirignotta F. Sleep disturbance and daytime sleepiness in patients with cirrhosis: a case control study. Neurol Sci. 2008;29:237-240. [PMID: 18810597 DOI: 10.1007/s10072-008-0973-7] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 4.1] [Reference Citation Analysis]
60 Metcalfe EL, Avenell A, Fraser A. Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: systematic review. Clin Nutr. 2014;33:958-965. [PMID: 24656171 DOI: 10.1016/j.clnu.2014.02.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
61 Feltracco P, Cagnin A, Carollo C, Barbieri S, Ori C. Neurological disorders in liver transplant candidates: Pathophysiology and clinical assessment. Transplantation Reviews 2017;31:193-206. [DOI: 10.1016/j.trre.2017.02.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
62 Zhang Y, Feng Y, Cao B, Tian Q. The effect of small intestinal bacterial overgrowth on minimal hepatic encephalopathy in patients with cirrhosis. Arch Med Sci. 2016;12:592-596. [PMID: 27279853 DOI: 10.5114/aoms.2015.55675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
63 Toris GT, Bikis CN, Tsourouflis GS, Theocharis SE. Hepatic encephalopathy: an updated approach from pathogenesis to treatment. Med Sci Monit 2011;17:RA53-63. [PMID: 21278704 DOI: 10.12659/msm.881387] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
64 García-martínez R, Córdoba J. Brain Imaging in Hepatic Encephalopathy. In: Mullen KD, Prakash RK, editors. Hepatic Encephalopathy. Totowa: Humana Press; 2012. pp. 123-37. [DOI: 10.1007/978-1-61779-836-8_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
65 Lauridsen MM, Thacker LR, White MB, Unser A, Sterling RK, Stravitz RT, Matherly S, Puri P, Sanyal AJ, Gavis EA, Luketic V, Siddiqui MS, Heuman DM, Fuchs M, Bajaj JS. In Patients With Cirrhosis, Driving Simulator Performance Is Associated With Real-life Driving. Clin Gastroenterol Hepatol 2016;14:747-52. [PMID: 26601613 DOI: 10.1016/j.cgh.2015.11.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
66 Qi R, Zhang LJ, Xu Q, Zhong J, Wu S, Zhang Z, Liao W, Ni L, Zhang Z, Chen H, Zhong Y, Jiao Q, Wu X, Fan X, Liu Y, Lu G. Selective impairments of resting-state networks in minimal hepatic encephalopathy.PLoS One. 2012;7:e37400. [PMID: 22662152 DOI: 10.1371/journal.pone.0037400] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
67 Vaisman N, Katzman H, Carmiel-Haggai M, Lusthaus M, Niv E. Breakfast improves cognitive function in cirrhotic patients with cognitive impairment. Am J Clin Nutr. 2010;92:137-140. [PMID: 20444959 DOI: 10.3945/ajcn.2010.29211] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
68 Mittal VV, Sharma BC, Sharma P, Sarin SK. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2011;23:725-732. [PMID: 21646910 DOI: 10.1097/meg.0b013e32834696f5] [Cited by in Crossref: 118] [Cited by in F6Publishing: 49] [Article Influence: 10.7] [Reference Citation Analysis]
69 Bhanji RA, Carey EJ, Watt KD. Review article: maximising quality of life while aspiring for quantity of life in end-stage liver disease. Aliment Pharmacol Ther. 2017;46:16-25. [PMID: 28464346 DOI: 10.1111/apt.14078] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
70 Bajaj JS, Hafeezullah M, Hoffmann RG, Varma RR, Franco J, Binion DG, Hammeke TA, Saeian K. Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology. 2008;47:596-604. [PMID: 18000989 DOI: 10.1002/hep.22032] [Cited by in Crossref: 113] [Cited by in F6Publishing: 96] [Article Influence: 8.1] [Reference Citation Analysis]
71 Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR, Gibson DP, Hoffmann RG, Stravitz RT, Heuman DM, Sterling RK, Shiffman M, Topaz A, Boyett S, Bell D, Sanyal AJ. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology. 2009;50:1175-1183. [PMID: 19670416 DOI: 10.1002/hep.23128] [Cited by in Crossref: 210] [Cited by in F6Publishing: 178] [Article Influence: 16.2] [Reference Citation Analysis]
72 Bajaj JS. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther. 2010;31:537-547. [PMID: 20002027 DOI: 10.1111/j.1365-2036.2009.04211.x] [Cited by in Crossref: 163] [Cited by in F6Publishing: 127] [Article Influence: 12.5] [Reference Citation Analysis]
73 Xia X, Chen J, Xia J, Wang B, Liu H, Yang L, Wang Y, Ling Z. Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. J Int Med Res 2018;46:3596-604. [PMID: 29806520 DOI: 10.1177/0300060518776064] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
74 McPhail MJ, Bajaj JS, Thomas HC, Taylor-Robinson SD. Pathogenesis and diagnosis of hepatic encephalopathy. Expert Rev Gastroenterol Hepatol. 2010;4:365-378. [PMID: 20528123 DOI: 10.1586/egh.10.32] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
75 Garcovich M, Zocco MA, Roccarina D, Ponziani FR, Gasbarrini A. Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota. World J Gastroenterol 2012; 18(46): 6693-6700 [PMID: 23239905 DOI: 10.3748/wjg.v18.i46.6693] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
76 Zhuge W, Wen F, Ni Z, Zheng Z, Zhu X, Lin J, Wang J, Zhuge Q, Ding S. Dopamine Burden Triggers Cholesterol Overload Following Disruption of Synaptogenesis in Minimal Hepatic Encephalopathy. Neuroscience 2019;410:1-15. [PMID: 31078686 DOI: 10.1016/j.neuroscience.2019.04.056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
77 Sotil EU, Gottstein J, Ayala E, Randolph C, Blei AT. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl. 2009;15:184-192. [PMID: 19177446 DOI: 10.1002/lt.21593] [Cited by in Crossref: 107] [Cited by in F6Publishing: 91] [Article Influence: 8.2] [Reference Citation Analysis]
78 Romeiro FG, Augusti L. Nutritional assessment in cirrhotic patients with hepatic encephalopathy. World J Hepatol 2015; 7(30): 2940-2954 [PMID: 26730273 DOI: 10.4254/wjh.v7.i30.2940] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
79 Long B, Koyfman A. The emergency medicine evaluation and management of the patient with cirrhosis. The American Journal of Emergency Medicine 2018;36:689-98. [DOI: 10.1016/j.ajem.2017.12.047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
80 Bajaj JS, Duarte-Rojo A, Xie JJ, Acharya C, Wade JB, Robles C, Thacker LR, Flud C, Fagan A, Garcia-Saenz-de-Sicilia M, White MB, Kelly M, Nguyen V, Gavis EA, Vargas HE. Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis. Clin Gastroenterol Hepatol 2020;18:3008-3016.e2. [PMID: 32205222 DOI: 10.1016/j.cgh.2020.03.033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
81 Bajaj JS, Saeian K, Hafeezullah M, Hoffmann RG, Hammeke TA. Patients with minimal hepatic encephalopathy have poor insight into their driving skills. Clin Gastroenterol Hepatol. 2008;6:1135-9; quiz 1065. [PMID: 18928938 DOI: 10.1016/j.cgh.2008.05.025] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
82 Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, Saeian K, Hafeezullah M, Bell DE, Sterling RK. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138:2332-2340. [PMID: 20178797 DOI: 10.1038/ajg.2011.490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
83 Córdoba J, García-Martinez R, Simón-Talero M. Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence. Metab Brain Dis. 2010;25:73-80. [PMID: 20217202 DOI: 10.1007/s11011-010-9172-3] [Cited by in Crossref: 67] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
84 American Association for the Study of Liver Diseases. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol. 2014;61:642-659. [PMID: 25015420 DOI: 10.1016/j.jhep.2014.05.042] [Cited by in Crossref: 212] [Cited by in F6Publishing: 164] [Article Influence: 26.5] [Reference Citation Analysis]
85 Labenz C, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU, Galle PR, Wörns MA. Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy. J Clin Gastroenterol 2019;53:e303-7. [PMID: 30439761 DOI: 10.1097/MCG.0000000000001149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
86 Zucco GM, Amodio P, Gatta A. Olfactory deficits in patients affected by minimal hepatic encephalopathy: a pilot study. Chem Senses 2006;31:273-8. [PMID: 16436687 DOI: 10.1093/chemse/bjj029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
87 Nabi E, Thacker LR, Wade JB, Sterling RK, Stravitz RT, Fuchs M, Heuman DM, Bouneva I, Sanyal AJ, Siddiqui MS. Diagnosis of covert hepatic encephalopathy without specialized tests. Clin Gastroenterol Hepatol. 2014;12:1384-1389.e2. [PMID: 24362049 DOI: 10.1016/j.cgh.2013.12.020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
88 Goyal O, Sidhu SS, Kishore H. Minimal hepatic encephalopathy in cirrhosis- how long to treat? Ann Hepatol. 2017;16:115-122. [PMID: 28051800 DOI: 10.5604/16652681.1226822] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
89 Seo YS, Yim SY, Jung JY, Kim CH, Kim JD, Keum B, An H, Yim HJ, Lee HS, Kim CD, Ryu HS, Um SH. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis. J Gastroenterol Hepatol. 2012;27:1695-1704. [PMID: 22743001 DOI: 10.1111/j.1440-1746.2012.07217.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
90 Agrawal A, Sharma BC, Sharma P, Sarin SK. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Am J Gastroenterol. 2012;107:1043-1050. [PMID: 22710579 DOI: 10.1038/ajg.2012.113] [Cited by in Crossref: 138] [Cited by in F6Publishing: 114] [Article Influence: 13.8] [Reference Citation Analysis]
91 Flamm SL. Covert Hepatic Encephalopathy: Who Should Be Tested and Treated? Clin Liver Dis 2015;19:473-85. [PMID: 26195202 DOI: 10.1016/j.cld.2015.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
92 Ichikawa T, Naota T, Miyaaki H, Miuma S, Isomoto H, Takeshima F, Nakao K. Effect of an oral branched chain amino acid-enriched snack in cirrhotic patients with sleep disturbance. Hepatol Res. 2010;40:971-978. [PMID: 20887332 DOI: 10.1111/j.1872-034x.2010.00701.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
93 Holecek M. Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives. Metab Brain Dis 2014;29:9-17. [PMID: 23996300 DOI: 10.1007/s11011-013-9428-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
94 Foster KJ, Lin S, Turck CJ. Current and emerging strategies for treating hepatic encephalopathy. Crit Care Nurs Clin North Am. 2010;22:341-350. [PMID: 20691385 DOI: 10.1016/j.ccell.2010.04.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
95 Holte K, Krag A, Gluud LL. Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy. Hepatol Res 2012;42:1008-15. [PMID: 22548675 DOI: 10.1111/j.1872-034X.2012.01015.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 3.9] [Reference Citation Analysis]
96 Qi R, Xu Q, Zhang LJ, Zhong J, Zheng G, Wu S, Zhang Z, Liao W, Zhong Y, Ni L. Structural and functional abnormalities of default mode network in minimal hepatic encephalopathy: a study combining DTI and fMRI. PLoS One. 2012;7:e41376. [PMID: 22911787 DOI: 10.1371/journal.pone.0041376] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
97 Johansson M, Strömberg J, Ragagnin G, Doverskog M, Bäckström T. GABAA receptor modulating steroid antagonists (GAMSA) are functional in vivo. J Steroid Biochem Mol Biol 2016;160:98-105. [PMID: 26523675 DOI: 10.1016/j.jsbmb.2015.10.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
98 Bamji N, Cohen LB. Endoscopic sedation of patients with chronic liver disease. Clin Liver Dis. 2010;14:185-194. [PMID: 20682228 DOI: 10.1016/j.cld.2010.03.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
99 Patidar KR, Thacker LR, Wade JB, Sterling RK, Sanyal AJ, Siddiqui MS, Matherly SC, Stravitz RT, Puri P, Luketic VA, Fuchs M, White MB, Noble NA, Unser AB, Gilles H, Heuman DM, Bajaj JS. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol. 2014;109:1757-1763. [PMID: 25178701 DOI: 10.1038/ajg.2014.264] [Cited by in Crossref: 99] [Cited by in F6Publishing: 79] [Article Influence: 12.4] [Reference Citation Analysis]
100 Sharma P, Sharma BC, Puri V, Sarin SK. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2008;20:506-511. [PMID: 18467909 DOI: 10.1097/meg.0b013e3282f3e6f5] [Cited by in Crossref: 120] [Cited by in F6Publishing: 37] [Article Influence: 9.2] [Reference Citation Analysis]
101 Bajaj JS. Management options for minimal hepatic encephalopathy. Expert Rev Gastroenterol Hepatol. 2008;2:785-790. [PMID: 19090738 DOI: 10.1586/17474124.2.6.785] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
102 Labenz C, Baron JS, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients. Aliment Pharmacol Ther. 2018;48:313-321. [PMID: 29863286 DOI: 10.1111/apt.14824] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
103 Lima LCD, Miranda AS, Ferreira RN, Rachid MA, Simões e Silva AC. Hepatic encephalopathy: Lessons from preclinical studies. World J Hepatol 2019; 11(2): 173-185 [PMID: 30820267 DOI: 10.4254/wjh.v11.i2.173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
104 Moratalla A, Ampuero J, Bellot P, Gallego-Durán R, Zapater P, Roger M, Figueruela B, Martínez-Moreno B, González-Navajas JM, Such J, Romero-Gómez M, Francés R. Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy. Liver Int 2017;37:212-23. [PMID: 27388776 DOI: 10.1111/liv.13200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
105 Luo M, Guo JY, Cao WK. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis. World J Gastroenterol 2015; 21(41): 11815-11824 [PMID: 26557005 DOI: 10.3748/wjg.v21.i41.11815] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
106 Bajaj JS. The role of microbiota in hepatic encephalopathy. Gut Microbes. 2014;5:397-403. [PMID: 24690956 DOI: 10.4161/gmic.28684] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 10.8] [Reference Citation Analysis]
107 Stawicka A, Jaroszewicz J, Zbrzeźniak J, Sołowianowicz N, Woszczenko A, Świderska M, Flisiak R. Clinical Usefulness of the Inhibitory Control Test (ICT) in the Diagnosis of Minimal Hepatic Encephalopathy. Int J Environ Res Public Health 2020;17:E3645. [PMID: 32455895 DOI: 10.3390/ijerph17103645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Subasinghe SK, Nandamuni Y, Ranasinghe S, Niriella MA, Miththinda JK, Dassanayake A, de Silva AP, de Silva HJ. Association between road accidents and low-grade hepatic encephalopathy among Sri Lankan drivers with cirrhosis: a prospective case control study. BMC Res Notes 2016;9:303. [PMID: 27296988 DOI: 10.1186/s13104-016-2106-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
109 Kim M, Liotta EM, Zee PC, Ganger DR, Ladner DP, Karmarkar A, Peipert JD, Sorond FA, Prabhakaran S, Reid KJ, Naidech AM, Maas MB. Impaired cognition predicts the risk of hospitalization and death in cirrhosis. Ann Clin Transl Neurol 2019;6:2282-90. [PMID: 31631586 DOI: 10.1002/acn3.50924] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
110 Cunniffe N, Munby H, Chan S, Saatci D, Edison E, Carpenter RHS, Massey D. Using saccades to diagnose covert hepatic encephalopathy. Metab Brain Dis 2015;30:821-8. [DOI: 10.1007/s11011-014-9647-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
111 Tranah TH, Vijay GK, Ryan JM, Shawcross DL. Systemic inflammation and ammonia in hepatic encephalopathy. Metab Brain Dis. 2013;28:1-5. [PMID: 23224356 DOI: 10.1007/s11011-012-9370-2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
112 Lauridsen MM, Jepsen P, Vilstrup H. Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis. 2011;26:135-139. [PMID: 21484318 DOI: 10.1007/s11011-011-9242-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
113 Hassanein T. Current state of knowledge of hepatic encephalopathy (part IV): Management of Hepatic Encephalopathy by liver support systems. Metab Brain Dis 2017;32:303-6. [PMID: 28013444 DOI: 10.1007/s11011-016-9911-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Stawicka A, Świderska M, Zbrzeźniak J, Sołowianowicz N, Woszczenko A, Flisiak R, Jaroszewicz J. Brain-derived neurotrophic factor as a potential diagnostic marker in minimal hepatic encephalopathy. Clin Exp Hepatol 2021;7:117-24. [PMID: 34027124 DOI: 10.5114/ceh.2021.103242] [Reference Citation Analysis]
115 Arias N, Méndez M, Arias J. Differential contribution of the hippocampus in two different demanding tasks at early stages of hepatic encephalopathy. Neuroscience 2015;284:1-10. [DOI: 10.1016/j.neuroscience.2014.08.060] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
116 Kim Y, Park G, Lee M, Lee J. Impairment of Driving Ability and Neuropsychological Function in Patients with MHE Disease. CyberPsychology & Behavior 2009;12:433-6. [DOI: 10.1089/cpb.2008.0242] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
117 Bajaj JS, Thacker LR, Heuman DM, Fuchs M, Sterling RK, Sanyal AJ, Puri P, Siddiqui MS, Stravitz RT, Bouneva I, Luketic V, Noble N, White MB, Monteith P, Unser A, Wade JB. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy. Hepatology. 2013;58:1122-1132. [PMID: 23389962 DOI: 10.1002/hep.26309] [Cited by in Crossref: 111] [Cited by in F6Publishing: 95] [Article Influence: 12.3] [Reference Citation Analysis]
118 Mina A, Moran S, Ortiz-Olvera N, Mera R, Uribe M. Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis. Hepatol Res. 2014;44:E92-E99. [PMID: 24033755 DOI: 10.1111/hepr.12227] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
119 Bruetto RG, Rodrigues FB, Torres US, Otaviano AP, Zanetta DM, Burdmann EA. Renal function at hospital admission and mortality due to acute kidney injury after myocardial infarction. PLoS One. 2012;7:e35496. [PMID: 22539974 DOI: 10.1371/journal.pone] [Cited by in F6Publishing: 90] [Reference Citation Analysis]
120 Kappus MR, Bajaj JS. Assessment of minimal hepatic encephalopathy (with emphasis on computerized psychometric tests). Clin Liver Dis. 2012;16:43-55. [PMID: 22321464 DOI: 10.1016/j.cld.2011.12.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
121 de Souza KZ, Zago-Gomes MP. Frontal assessment battery: A tool for screening minimal hepatic encephalopathy? World J Hepatol 2016; 8(30): 1262-1268 [PMID: 27843536 DOI: 10.4254/wjh.v8.i30.1262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
122 Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology. 2008;134:1715-1728. [PMID: 18471549 DOI: 10.1053/j.gastro.2008.03.007] [Cited by in Crossref: 215] [Cited by in F6Publishing: 174] [Article Influence: 15.4] [Reference Citation Analysis]
123 Burkard T, Biedermann A, Herold C, Dietlein M, Rauch M, Diefenbach M. Treatment with a potassium-iron-phosphate-citrate complex improves PSE scores and quality of life in patients with minimal hepatic encephalopathy: a multicenter, randomized, placebo-controlled, double-blind clinical trial. Eur J Gastroenterol Hepatol. 2013;25:352-358. [PMID: 23117470 DOI: 10.1097/MEG.0b013e32835afaa5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
124 Tiberi O, Tognarelli JM, Cook NA, Crossey MM, Dhanjal NS, Taylor-Robinson SD. Diagnosing and treating hepatic encephalopathy. Br J Hosp Med (Lond) 2015;76:646, 648-52, 654. [PMID: 26551495 DOI: 10.12968/hmed.2015.76.11.646] [Reference Citation Analysis]
125 White H. Neurologic manifestations of acute and chronic liver disease. Continuum (Minneap Minn). 2014;20:670-680. [PMID: 24893241 DOI: 10.1212/01.con.0000450973.84075.a7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
126 Saleh DO, Mansour DF, Fayez AM. Thioacetamide-induced acute hepatic encephalopathy: central vs peripheral effect of Allicin. Metab Brain Dis 2021;36:1331-40. [PMID: 33765229 DOI: 10.1007/s11011-021-00695-7] [Reference Citation Analysis]
127 Kaji K, Saikawa S, Takaya H, Fujinaga Y, Furukawa M, Kitagawa K, Ozutsumi T, Kaya D, Tsuji Y, Sawada Y, Kawaratani H, Moriya K, Namisaki T, Akahane T, Mitoro A, Yoshiji H. Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients. Antibiotics (Basel). 2020;9. [PMID: 32235367 DOI: 10.3390/antibiotics9040145] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
128 Soriano G, Román E, Córdoba J, Torrens M, Poca M, Torras X, Villanueva C, Gich IJ, Vargas V, Guarner C. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology 2012;55:1922-30. [PMID: 22213000 DOI: 10.1002/hep.25554] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 6.8] [Reference Citation Analysis]
129 Ridola L, Cardinale V, Riggio O. The burden of minimal hepatic encephalopathy: From diagnosis to therapeutic strategies. Ann Gastroenterol. 2018;31:151-164. [PMID: 29507462 DOI: 10.20524/aog.2018.0232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
130 Román E, Córdoba J, Torrens M, Torras X, Villanueva C, Vargas V, Guarner C, Soriano G. Minimal Hepatic Encephalopathy Is Associated With Falls. American Journal of Gastroenterology 2011;106:476-82. [DOI: 10.1038/ajg.2010.413] [Cited by in Crossref: 120] [Cited by in F6Publishing: 111] [Article Influence: 10.9] [Reference Citation Analysis]
131 Thomsen KL, Macnaughtan J, Tritto G, Mookerjee RP, Jalan R. Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy. PLoS One. 2016;11:e0146076. [PMID: 26745876 DOI: 10.1371/journal.pone.0146076] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
132 Iduru S, Hisamuddin K, Mullen KD. Minimal Hepatic Encephalopathy: Simplifying Its Diagnosis. Am J Gastroenterology 2007;102:1537-8. [DOI: 10.1111/j.1572-0241.2007.01188.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
133 Bianchi G, Giovagnoli M, Sasdelli AS, Marchesini G. Hepatic encephalopathy and health-related quality of life. Clin Liver Dis 2012;16:159-70. [PMID: 22321471 DOI: 10.1016/j.cld.2011.12.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
134 Ditisheim S, Giostra E, Burkhard PR, Goossens N, Mentha G, Hadengue A, Spahr L. A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis. BMC Gastroenterol 2011;11:134. [PMID: 22151412 DOI: 10.1186/1471-230X-11-134] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
135 Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol. 2011;106:307-316. [PMID: 21157444 DOI: 10.1038/ajg.2010.455] [Cited by in Crossref: 155] [Cited by in F6Publishing: 138] [Article Influence: 12.9] [Reference Citation Analysis]
136 Bajaj JS, Pinkerton SD, Sanyal AJ, Heuman DM. Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis. Hepatology 2012;55:1164-71. [PMID: 22135042 DOI: 10.1002/hep.25507] [Cited by in Crossref: 85] [Cited by in F6Publishing: 73] [Article Influence: 8.5] [Reference Citation Analysis]
137 Zhang W, Ning N, Li X, Li M, Duan X, Guo Y, Dang Y, Li Y, Gao J, Ye J, Yang J. Impaired brain glucose metabolism in cirrhosis without overt hepatic encephalopathy: a retrospective 18F-FDG PET/CT study. Neuroreport 2019;30:776-82. [PMID: 31261240 DOI: 10.1097/WNR.0000000000001284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Wilkinson DJ, Smeeton NJ, Castle PC, Watt PW. Absence of neuropsychological impairment in hyperammonaemia in healthy young adults; possible synergism in development of hepatic encephalopathy (HE) symptoms? Metab Brain Dis. 2011;26:203-212. [PMID: 21773808 DOI: 10.1007/s11011-011-9251-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
139 Patidar KR, Bajaj JS. Covert and Overt Hepatic Encephalopathy: Diagnosis and Management. Clin Gastroenterol Hepatol 2015;13:2048-61. [PMID: 26164219 DOI: 10.1016/j.cgh.2015.06.039] [Cited by in Crossref: 87] [Cited by in F6Publishing: 65] [Article Influence: 12.4] [Reference Citation Analysis]
140 Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther. 2007;25 Suppl 1:3-9. [PMID: 17295846 DOI: 10.1111/j.1746-6342.2006.03215.x] [Cited by in Crossref: 238] [Cited by in F6Publishing: 200] [Article Influence: 15.9] [Reference Citation Analysis]
141 Sharma K, Pant S, Misra S, Dwivedi M, Misra A, Narang S, Tewari R, Bhadoria AS. Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial. Saudi J Gastroenterol. 2014;20:225-232. [PMID: 25038208 DOI: 10.4103/1319-3767.136975] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
142 Duarte-Rojo A, Ruiz-Margáin A, Macias-Rodriguez RU, Cubero FJ, Estradas-Trujillo J, Muñoz-Fuentes RM, Torre A. Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy. World J Gastroenterol 2016; 22(17): 4397-4402 [PMID: 27158209 DOI: 10.3748/wjg.v22.i17.4397] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
143 Cordoba J. Hepatic Encephalopathy: From the Pathogenesis to the New Treatments. ISRN Hepatol 2014;2014:236268. [PMID: 27335836 DOI: 10.1155/2014/236268] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
144 Bajaj JS, Hafeezullah M, Franco J, Varma RR, Hoffmann RG, Knox JF, Hischke D, Hammeke TA, Pinkerton SD, Saeian K. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology. 2008;135:1591-1600.e1. [PMID: 18723018 DOI: 10.1053/j.gastro.2008.07.021] [Cited by in Crossref: 149] [Cited by in F6Publishing: 142] [Article Influence: 10.6] [Reference Citation Analysis]
145 Nardone R, Taylor AC, Höller Y, Brigo F, Lochner P, Trinka E. Minimal hepatic encephalopathy: A review. Neurosci Res 2016;111:1-12. [PMID: 27153746 DOI: 10.1016/j.neures.2016.04.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
146 Suh SJ, Yim HJ, Yoon EL, Lee BJ, Hyun JJ, Jung SW, Koo JS, Kim JH, Kim KJ, Choung RS, Seo YS, Yeon JE, Um SH, Byun KS, Lee SW, Choi JH, Ryu HS. Is propofol safe when administered to cirrhotic patients during sedative endoscopy? Korean J Intern Med. 2014;29:57-65. [PMID: 24574834 DOI: 10.3904/kjim.2014.29.1.57] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
147 Romero Gómez M, Córdoba J, Jover R, del Olmo J, Fernández A, Flavià M, Compañy L, Poveda MJ, Felipo V; Red Nacional de Investigación en Encefalopatía Hepática. [Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy]. Med Clin (Barc) 2006;127:246-9. [PMID: 16942726 DOI: 10.1157/13091264] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
148 Waghray A, Waghray N, Mullen K. Management of covert hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S75-81. [PMID: 26041963 DOI: 10.1016/j.jceh.2014.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
149 Moran S, López-Sánchez M, Milke-García MDP, Rodríguez-Leal G. Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis. World J Gastroenterol 2021; 27(22): 3050-3063 [PMID: 34168407 DOI: 10.3748/wjg.v27.i22.3050] [Reference Citation Analysis]
150 Ahluwalia V, Wade JB, Heuman DM, Hammeke TA, Sanyal AJ, Sterling RK, Stravitz RT, Luketic V, Siddiqui MS, Puri P, Fuchs M, Lennon MJ, Kraft KA, Gilles H, White MB, Noble NA, Bajaj JS. Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis. Metab Brain Dis. 2014;29:1017-1025. [PMID: 24590688 DOI: 10.1007/s11011-014-9507-6] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
151 Pereira K, Carrion AF, Martin P, Vaheesan K, Salsamendi J, Doshi M, Yrizarry JM. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy. Liver Int. 2015;35:2487-2494. [PMID: 26332169 DOI: 10.1111/liv.12956] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
152 Mancini A, Campagna F, Amodio P, Tuohy KM. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy. Food Funct. 2018;9:1373-1388. [PMID: 29485654 DOI: 10.1039/c7fo01528c] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
153 Bajaj JS, Riggio O, Allampati S, Prakash R, Gioia S, Onori E, Piazza N, Noble NA, White MB, Mullen KD. Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: An international multicenter study. Clin Gastroenterol Hepatol. 2013;11:1511-1516. [PMID: 23707462 DOI: 10.1016/j.cgh.2013.05.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
154 Dbouk N, McGuire BM. Hepatic encephalopathy: a review of its pathophysiology and treatment. Curr Treat Options Gastroenterol 2006;9:464-74. [PMID: 17081480 DOI: 10.1007/s11938-006-0003-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
155 Córdoba J. New assessment of hepatic encephalopathy. J Hepatol. 2011;54:1030-1040. [PMID: 21145874 DOI: 10.1016/j.jhep.2010.11.015] [Cited by in Crossref: 143] [Cited by in F6Publishing: 120] [Article Influence: 11.9] [Reference Citation Analysis]
156 Thuluvath PJ, Nuthalapati A, Price J, Maheshwari A. Driving Performance Among Patients with Cirrhosis Who Drove to Their Outpatient Hepatology Clinic Appointments. J Clin Exp Hepatol 2016;6:3-9. [PMID: 27194889 DOI: 10.1016/j.jceh.2015.09.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
157 Taniguchi E, Kawaguchi T, Sakata M, Itou M, Oriishi T, Sata M. Lipid profile is associated with the incidence of cognitive dysfunction in viral cirrhotic patients: A data-mining analysis: Cognition-related lipid profile in liver cirrhosis. Hepatology Research 2013;43:418-24. [DOI: 10.1111/j.1872-034x.2012.01076.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
158 Bajaj JS. Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 2008; 14(23): 3609-3615 [PMID: 18595126 DOI: 10.3748/wjg.14.3609] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 87] [Article Influence: 7.0] [Reference Citation Analysis]
159 Ferenci P. Hepatic encephalopathy. Gastroenterol Rep (Oxf). 2017;5:138-147. [PMID: 28533911 DOI: 10.1093/gastro/gox013] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
160 Bajaj JS, Etemadian A, Hafeezullah M, Saeian K. Testing for minimal hepatic encephalopathy in the United States: An AASLD survey. Hepatology. 2007;45:833-834. [PMID: 17326210 DOI: 10.1002/hep.21515] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 7.1] [Reference Citation Analysis]
161 Rovira A, Alonso J, Córdoba J. MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol 2008;29:1612-21. [PMID: 18583413 DOI: 10.3174/ajnr.A1139] [Cited by in Crossref: 211] [Cited by in F6Publishing: 75] [Article Influence: 15.1] [Reference Citation Analysis]
162 Yao C, Huang G, Wang M, Xia M, Yao F, Niu D, Zhang Y, Li S, Zhong Y. Chinese herbal medicine formula Jieduhuayu granules improves cognitive and neurophysiological functions in patients with cirrhosis who have minimal hepatic encephalopathy: a randomized controlled trial. Complement Ther Med. 2014;22:977-985. [PMID: 25453517 DOI: 10.1016/j.ctim.2014.10.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
163 Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45:549-559. [PMID: 17326150 DOI: 10.1002/hep.21533] [Cited by in Crossref: 385] [Cited by in F6Publishing: 325] [Article Influence: 25.7] [Reference Citation Analysis]
164 Amorós A, Aparicio JR, Garmendia M, Casellas JA, Martínez J, Jover R. Deep sedation with propofol does not precipitate hepatic encephalopathy during elective upper endoscopy. Gastrointest Endosc. 2009;70:262-268. [PMID: 19394004 DOI: 10.1016/j.gie.2008.10.038] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
165 Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: Evidence based treatment. World J Gastroenterol 2014; 20(18): 5442-5460 [PMID: 24833875 DOI: 10.3748/wjg.v20.i18.5442] [Cited by in CrossRef: 93] [Cited by in F6Publishing: 81] [Article Influence: 11.6] [Reference Citation Analysis]
166 Kaji K, Takaya H, Saikawa S, Furukawa M, Sato S, Kawaratani H, Kitade M, Moriya K, Namisaki T, Akahane T, Mitoro A, Yoshiji H. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity. World J Gastroenterol 2017; 23(47): 8355-8366 [PMID: 29307995 DOI: 10.3748/wjg.v23.i47.8355] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
167 Li Y, Mei L, Qiang J, Ju S, Zhao S. Magnetic Resonance Spectroscopy for Evaluating Portal-Systemic Encephalopathy in Patients with Chronic Hepatic Schistosomiasis Japonicum. PLoS Negl Trop Dis 2016;10:e0005232. [PMID: 27977668 DOI: 10.1371/journal.pntd.0005232] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
168 Kachaamy T, Bajaj JS. Diet and cognition in chronic liver disease. Curr Opin Gastroenterol 2011;27:174-9. [PMID: 20975555 DOI: 10.1097/MOG.0b013e3283409c25] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
169 Zamora Nava LE, Delgadillo AT. Minimal hepatic encephalopathy. Annals of Hepatology 2011;10:S50-4. [DOI: 10.1016/s1665-2681(19)31607-2] [Cited by in Crossref: 8] [Article Influence: 0.7] [Reference Citation Analysis]